Cargando…

Calcium dysregulation in atrial fibrillation: the role of CaMKII

Atrial fibrillation (AF) is the most frequently encountered clinical arrhythmia and is associated with increased morbidity and mortality. Ectopic activity and reentry are considered major arrhythmogenic mechanisms contributing to the initiation and maintenance of AF. In addition, AF is self-reinforc...

Descripción completa

Detalles Bibliográficos
Autores principales: Heijman, Jordi, Voigt, Niels, Wehrens, Xander H. T., Dobrev, Dobromir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940963/
https://www.ncbi.nlm.nih.gov/pubmed/24624086
http://dx.doi.org/10.3389/fphar.2014.00030
_version_ 1782305845291253760
author Heijman, Jordi
Voigt, Niels
Wehrens, Xander H. T.
Dobrev, Dobromir
author_facet Heijman, Jordi
Voigt, Niels
Wehrens, Xander H. T.
Dobrev, Dobromir
author_sort Heijman, Jordi
collection PubMed
description Atrial fibrillation (AF) is the most frequently encountered clinical arrhythmia and is associated with increased morbidity and mortality. Ectopic activity and reentry are considered major arrhythmogenic mechanisms contributing to the initiation and maintenance of AF. In addition, AF is self-reinforcing through progressive electrical and structural remodeling which stabilize the arrhythmia and make it more difficult to treat. Recent research has suggested an important role for Ca(2+)-dysregulation in AF. Ca(2+)-handling abnormalities may promote ectopic activity, conduction abnormalities facilitating reentry, and AF-related remodeling. In this review article, we summarize the Ca(2+)-handling derangements occurring in AF and discuss their impact on fundamental arrhythmogenic mechanisms. We focus in particular on the role of the multifunctional Ca(2+)/calmodulin-dependent protein kinase type-II (CaMKII), which acts as a major link between Ca(2+)-dysregulation and arrhythmogenesis. CaMKII expression and activity are increased in AF and promote arrhythmogenesis through phosphorylation of various targets involved in cardiac electrophysiology and excitation-contraction coupling. We discuss the implications for potential novel therapeutic strategies for AF based on CaMKII and Ca(2+)-handling abnormalities.
format Online
Article
Text
id pubmed-3940963
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-39409632014-03-12 Calcium dysregulation in atrial fibrillation: the role of CaMKII Heijman, Jordi Voigt, Niels Wehrens, Xander H. T. Dobrev, Dobromir Front Pharmacol Pharmacology Atrial fibrillation (AF) is the most frequently encountered clinical arrhythmia and is associated with increased morbidity and mortality. Ectopic activity and reentry are considered major arrhythmogenic mechanisms contributing to the initiation and maintenance of AF. In addition, AF is self-reinforcing through progressive electrical and structural remodeling which stabilize the arrhythmia and make it more difficult to treat. Recent research has suggested an important role for Ca(2+)-dysregulation in AF. Ca(2+)-handling abnormalities may promote ectopic activity, conduction abnormalities facilitating reentry, and AF-related remodeling. In this review article, we summarize the Ca(2+)-handling derangements occurring in AF and discuss their impact on fundamental arrhythmogenic mechanisms. We focus in particular on the role of the multifunctional Ca(2+)/calmodulin-dependent protein kinase type-II (CaMKII), which acts as a major link between Ca(2+)-dysregulation and arrhythmogenesis. CaMKII expression and activity are increased in AF and promote arrhythmogenesis through phosphorylation of various targets involved in cardiac electrophysiology and excitation-contraction coupling. We discuss the implications for potential novel therapeutic strategies for AF based on CaMKII and Ca(2+)-handling abnormalities. Frontiers Media S.A. 2014-03-04 /pmc/articles/PMC3940963/ /pubmed/24624086 http://dx.doi.org/10.3389/fphar.2014.00030 Text en Copyright © 2014 Heijman, Voigt, Wehrens and Dobrev. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Heijman, Jordi
Voigt, Niels
Wehrens, Xander H. T.
Dobrev, Dobromir
Calcium dysregulation in atrial fibrillation: the role of CaMKII
title Calcium dysregulation in atrial fibrillation: the role of CaMKII
title_full Calcium dysregulation in atrial fibrillation: the role of CaMKII
title_fullStr Calcium dysregulation in atrial fibrillation: the role of CaMKII
title_full_unstemmed Calcium dysregulation in atrial fibrillation: the role of CaMKII
title_short Calcium dysregulation in atrial fibrillation: the role of CaMKII
title_sort calcium dysregulation in atrial fibrillation: the role of camkii
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940963/
https://www.ncbi.nlm.nih.gov/pubmed/24624086
http://dx.doi.org/10.3389/fphar.2014.00030
work_keys_str_mv AT heijmanjordi calciumdysregulationinatrialfibrillationtheroleofcamkii
AT voigtniels calciumdysregulationinatrialfibrillationtheroleofcamkii
AT wehrensxanderht calciumdysregulationinatrialfibrillationtheroleofcamkii
AT dobrevdobromir calciumdysregulationinatrialfibrillationtheroleofcamkii